HealthEquity, Inc.
General ticker "HQY" information:
- Sector: Health Care
- Industry: Health Care Providers & Services
- Capitalization: $8.4B (TTM average)
HealthEquity, Inc. follows the US Stock Market performance with the rate: 29.6%.
Estimated limits based on current volatility of 2.7%: low 97.31$, high 102.68$
Factors to consider:
- Total employees count: 3105 (-0.7%) as of 2025
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Tax benefits loss, Market competition, Cybersecurity threats, Third-party risks, Service provider risks
- Price in estimated range
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-01-31 to 2027-01-31
- 2025-01-31 to 2026-01-31 estimated range: [80.16$, 126.03$]
- 2026-01-31 to 2027-01-31 estimated range: [74.85$, 119.87$]
Financial Metrics affecting the HQY estimates:
- Negative: with PPE of 34.2 at the end of fiscal year the price was very high
- Positive: 7.86 < Operating profit margin, % of 13.53
- Negative: negative Industry operating cash flow (median)
- Positive: Interest expense per share per price, % of 0.65 <= 0.79
- Positive: 1.87 < Return on assets ratio (scaled to [-100,100]) of 2.73
- Positive: 41.86 < Shareholder equity ratio, % of 61.33 <= 63.39
- Positive: -14.38 < Investing cash flow per share per price, % of -5.43
- Positive: 0.33 < Operating cash flow per share per price, % of 3.65
Short-term HQY quotes
Long-term HQY plot with estimates
Financial data
| YTD | 2023-01-31 | 2024-01-31 | 2025-01-31 |
|---|---|---|---|
| Operating Revenue | $861.75MM | $999.59MM | $1,199.77MM |
| Operating Expenses | $852.69MM | $881.89MM | $1,037.44MM |
| Operating Income | $9.06MM | $117.70MM | $162.33MM |
| Non-Operating Income | $-47.15MM | $-42.66MM | $-46.30MM |
| Interest Expense | $48.42MM | $55.45MM | $60.63MM |
| R&D Expense | $193.38MM | $218.81MM | $239.51MM |
| Income(Loss) | $-38.10MM | $75.04MM | $116.03MM |
| Taxes | $-11.95MM | $19.33MM | $19.33MM |
| Profit(Loss)* | $-26.14MM | $55.71MM | $96.70MM |
| Stockholders Equity | $1,895.64MM | $2,035.02MM | $2,114.91MM |
| Assets | $3,088.90MM | $3,163.79MM | $3,448.55MM |
| Operating Cash Flow | $150.65MM | $242.83MM | $339.86MM |
| Capital expenditure | $119.13MM | $46.07MM | $2.08MM |
| Investing Cash Flow | $-119.13MM | $-46.07MM | $-505.45MM |
| Financing Cash Flow | $-2.67MM | $-47.04MM | $57.57MM |
| Earnings Per Share** | $-0.31 | $0.65 | $1.11 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.